The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens.
Diagn Microbiol Infect Dis
; 90(1): 64-66, 2018 Jan.
Article
en En
| MEDLINE
| ID: mdl-29103875
The in vitro antimicrobial activity of iclaprim, a novel diaminopyrimidine, against common respiratory bacteria remained unchanged in the presence of pulmonary surfactant (Survanta®) at concentrations that greatly antagonized the antimicrobial activity of daptomycin. These results indicate that iclaprim could be a potential treatment for pneumonia caused by susceptible and multidrug resistant bacteria.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
4_TD
Problema de salud:
4_pneumonia
Asunto principal:
Pirimidinas
/
Bacterias
/
Surfactantes Pulmonares
/
Neumonía Bacteriana
/
Antagonistas del Ácido Fólico
/
Antibacterianos
Límite:
Humans
Idioma:
En
Revista:
Diagn Microbiol Infect Dis
Año:
2018
Tipo del documento:
Article